Bispecific Antibodies Market 2026: Growth And Revenue Analysis By Top Key Players -Amgen, Bayer AG, Dow Pharmaceutical Solutions, ImmunGene
Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to acytotoxic cell and target tumor cell and destroys it. Bispecific antibodies are emerging a technologically advanced solution for dual targeting strategies within same molecule.
Bispecific antibodies can be divided into three main classes namely, fragment, symmetric, and asymmetric antibodies. Fragment bispecific antibodies such as a nanobody DART and BiTE are currently undergoing clinical trials. Likewise, tetravalent BsAb - DVD and DAF symmetric antibodies are under research. Companies such as Sanofi S.A., Merck & Co., Inc. and Genentech, Inc. are conducting research on symmetric bispecific antibodies. BEAT, duobody, and crossmab are examples of asymmetric bispecific antibodies, which are currently being researched by Glenmark Pharmaceuticals, Eli Lilly and Company, and Genmab A/S.
Request For a Sample Copy of This Research Report: www.coherentmarketinsights.com/insight/request-sample/19
Catumaxomab – the first Bispecific antibody boost growth of the bispecific antibodies market
As of 2015, over 60 different BsAb formats have been developed, with some making their way into the clinical trials. Bispecific antibodies market growth is increasing due to the limitation of monoclonal antibodies in drug resistance and failure to respond in treatment. Hence, the bispecific antibodies market is projected to gain significant growth traction in the near future.
Catumaxomab is a rat – mouse hybrid monoclonal bispecific trifunctional antibody used to treat malignant ascites. It was developed by Fresenius Biotech and Trion Pharma. Catumaxomab was approved in Europe in 2009 and is undergoing clinical trials in the U.S. Sold under the brand name Removab, Catumaxomab is administered to patients with EpCAM-poisitve carcinoma.
North America and Europe are major regions for Bispecific antibodies market
In Europe and North America, incidence of diseases such as lung cancer, cervical cancer, breast cancer, and prostate cancer is increasing, with the regions accounting for the highest incidence rate for these diseases worldwide. Moreover, with these regions being home to major players, these are the largest bispecific antibodies market. Supportive government initiatives are further fueling growth of bispecific antibody treatment markets in North America and Europe. Increasing healthcare access and awareness in developing regions such as Asia Pacific, Latin America, and Middle East are projected to propel demand for BsAb owing to fuel growth of the bispecific antibodies market in the near future.
Increasing investments to harness the potential of highly effective BsAb Drug Therapy
Various pharmaceutical companies are actively involved in development and manufacture of bispecific antibodies. MedImmune, LLC and Abpro, collaborated in December 2016 to develop novel bispecific antibody, Ang2-VEGF, which targets angiopoietin-2 and vascular endothelial growth factor. Government funding is projected to further encourage research and development in this field.
Key players involved in the Bispecific antibodies market include
Some of the key players in Bispecific antibodies market are Amgen, Inc., Bayer AG, Dow Pharmaceutical Solutions, ImmunGene, Inc., Immunocore Limited, Merck & Co., Inc., Novartis AG, Pfizer, Inc., and F. Hoffmann-La Roche AG.
Download the PDF brochure: www.coherentmarketinsights.com/insight/request-pdf/19
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
1001 4th Ave,
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bispecific Antibodies Market 2026: Growth And Revenue Analysis By Top Key Players -Amgen, Bayer AG, Dow Pharmaceutical Solutions, ImmunGene here
News-ID: 1705711 • Views: 1007
More Releases from Coherent Market Insights
Racing Drones Market is Projected to Reach US$ 2,143.9 Million by 2026 | DJI, Pa …
The latest report by Coherent Market Insights, titled "Global Racing Drones Market Trends, Types, Report and Forecast 2022-2026," provides a detailed analysis of the market, evaluating it based on sales revenue, growth strategies, sales pattern, production, consumption, and supply-demand analysis of the industry with recent developments. The research explores the effects of the most recent market developments on the overall industry. Along with analysing the market using the SWOT and
ZigBee Market Revenue, Growth Opportunities and Business Development by 2028 | I …
The latest report by Coherent Market Insights, titled "Global ZigBee Market Trends, Types, Report and Forecast 2022-2028," provides a detailed analysis of the market, evaluating it based on sales revenue, growth strategies, sales pattern, production, consumption, and supply-demand analysis of the industry with recent developments. The research explores the effects of the most recent market developments on the overall industry. Along with analysing the market using the SWOT and Porter's
Indoor Positioning and Indoor Navigation (IPIN) Market Continues To Grow Owing T …
The "Indoor Positioning and Indoor Navigation (IPIN) Market" research report offers important information about the state of the sector. This research offers in-depth details on the industry's foundation, productivity, strengths, manufacturers, and current trends that support business expansion and economic strength. The study makes an effort to maintain a thorough analysis and offer a geographical overview of the worldwide Indoor Positioning and Indoor Navigation (IPIN) Market. The report covers key
Clear Aligners Market will generate new growth opportunities 2022-2028 | Align T …
Clear Aligners Market report studies the Clear Aligners with many aspects of the industry like the market size, market status, market trends and forecast, the report also provides brief information of the competitors and the specific growth opportunities with key market drivers. Find the complete Clear Aligners Market analysis segmented by companies, region, type and applications in the report. The research focuses on the drivers and restraints that impact market dynamics